News - BIOQuébec

14 October 2025
Feldan Therapeutics’ shuttle technology drives collaborative initiative suppoted by grant funding through Médicament Québec to advance mRNA Therapeutics
Feldan Shuttle technology is at the heart of a collaborative research initiative supported by…
Read more
14 October 2025
Anasens and MAVAND Sign Distribution Agreement for DrugAsens™ Across Key European Markets and Australia
Anasens Inc., a developer of rapid, connected point-of-care detection tools, today announced it has signed a distribution agreement with MAVAND Solutions…
Read more
17 September 2025
Biotech companies and academic institutions: considerations for successful collaboration
Grand nombre d’entreprises dans l’industrie des biotechnologies au Québec sont intéressées à collaborer avec une ou plusieurs institutions académiques…
Read more
14 August 2025
BIOQuébec in Winnipeg Free Press – Strengthening pan-Canadian collaboration
In a recent Winnipeg Free Press, our CEO Benoît Larose emphasized the importance of relying on Canadian strengths to build a…
Read more
12 August 2025
Bioeureka launches MicroSelect™ – a revolution in rapid pathogen identification
Bioeureka™, a leader in innovative technologies in the field of applied microbiology, announces the official launch of MicroSelect™, a unique…
Read more
12 August 2025
adMare Executive Institute Opens Applications for Eighth Cohort
The adMare Academy is now accepting applications for the eighth cohort of its exclusive Executive Institute, Canada’s premier leadership development…
Read more

December 2025 Newsletter

A rich legacy for your association Dear members of the ecosystem, The past year has been one of action and growth for BIOQuébec. In a particularly challenging geoeconomic context, we have redoubled our efforts to represent the interests of our industry to decision-makers and consistently remind them of the importance of our industry for the…

News &
publications

Discover our news, publications and the latest from our partners and members. Stay abreast of the advances and issues shaping Quebec's life sciences!

Feldan Therapeutics’ shuttle technology drives collaborative initiative suppoted by grant funding through Médicament Québec to advance mRNA Therapeutics

Anasens and MAVAND Sign Distribution Agreement for DrugAsens™ Across Key European Markets and Australia

Biotech companies and academic institutions: considerations for successful collaboration

BIOQuébec in Winnipeg Free Press – Strengthening pan-Canadian collaboration

Bioeureka launches MicroSelect™ – a revolution in rapid pathogen identification

adMare Executive Institute Opens Applications for Eighth Cohort

December 2025 Newsletter

News & publications

Discover our news, publications and the latest from our partners and members. Stay abreast of the advances and issues shaping Quebec's life sciences!

Feldan Therapeutics’ shuttle technology drives collaborative initiative suppoted by grant funding through Médicament Québec to advance mRNA Therapeutics

Anasens and MAVAND Sign Distribution Agreement for DrugAsens™ Across Key European Markets and Australia

Biotech companies and academic institutions: considerations for successful collaboration

BIOQuébec in Winnipeg Free Press – Strengthening pan-Canadian collaboration

Bioeureka launches MicroSelect™ – a revolution in rapid pathogen identification

adMare Executive Institute Opens Applications for Eighth Cohort

December 2025 Newsletter

News &
publications